Clinical and Translational Research

The Centre has a spectrum of research expertise that spans from clinical activity at one end to fundamental cancer biology at the other. The central strategy for the next 5-10 years will be to build on existing strengths producing an integrated translational research programme in which basic research identifies new drug targets, which can then be tested in clinical trials. Biomarker and drug resistance studies done as part of these trials can then indicate new areas for both clinical and basic research. The Centre will integrate basic research in cell biology, drug metabolism and chemistry with clinical research into pancreatic cancers, chronic leukaemias, head and neck cancers and eye cancers.

All of this research is directly relevant to the biology involved in our internationally recognized clinical specializations. The combination of expertise making up the Centre will allow us to pursue an integrated molecular, chemical, and clinical approach. Because of this we are in a strong position to identify novel targets for therapeutic agents, and novel biomarkers. By providing a forum to integrate these activities, the Liverpool Cancer Research UK Centre will promote the development of individualised therapies for cancer.

Groups Specialising in Clinical and Translational Research
Pancreatic:
Professor John Neoptolemos		Professor Daniel Palmer		Professor Paula Ghaneh		Dr Eithne Costello-Goldring		Dr Bill Greenhalf
Head and Neck:
Professor Terry Jones		Mr Richard Shaw		Dr Tim Helliwell